Testing effectiveness (Phase 2)Study completedNCT00067743
What this trial is testing
CC-5013 in the Treatment of Complex Regional Pain Syndrome (CRPS)
Who this might be right for
Complex Regional Pain Syndrome (RSD)
Celgene Corporation 40
Showing 13 of 13 results